United Breast Cancer Foundation (UBCF) was selected as the featured “Charity of Choice” for the second consecutive year and given the opportunity to air a public service announcement at theNASCAR Sprint Cup race Brickyard 400, helping to raise awareness about male breast cancer.
Brickyard 400 took place at the Indianapolis Motor Speedway on July 22–24. UBCF’s announcement aired every half-hour during the three-day event, reaching an estimated 1.3 million people — a mix of those in attendance and those watching the event on TV.
“It’s an honor to participate at the Brickyard 400 for the second year. We want to remind the community that UBCF is here to support men with breast cancer. Early detection is key — be sure to visit our website to download UBCF’s male self-breast exam,” Stephanie Mastroianni, UBCF’s executive director, said in a press release.
Besides encouraging men to learn how to do a breast self-exam, the organization believes it is important to always seek a second and third opinion – male breast cancer is often misdiagnosed in the early stages, when it is most easily treated.
UBCF estimates that 2,600 men will be diagnosed with breast cancer this year, and some 440 will die of the disease. One of the reasons for such a high mortality rate is that men are not well-aware of this disease, and not encouraged to do regular self-examinations or be screened for breast cancer.
UBCV offers breast health and wellness services focused on prevention, screening, and treatment. No one, regardless of age, race, gender, ethnicity, income, or medical insurance coverage is denied services. UBCF provides support and assistance through seven different patient and family programs.
UBCF also congratulates Kyle Busch for a second Brickyard 400 win, and for achieving a record 149 of 170 laps.
Scientists at The Institute of Cancer Research in London have tested the activity of two genes that could predict an increased risk of mortality for women with breast cancers. The study, “Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer,” was published in the journal Oncotarget.